44 Stocks Moving In Friday's Mid-Day Session

Gainers

• FTD Companies Inc FTD surges 112.8 percent to $0.30 after Diamond Investment Group reported a 12 percent stake in the company. FTD 50 LLC also disclosed a 12 percent stake in the company.
• Stewardship Financial Corporation SSFN shares gained 72.8 percent to $15.38. Columbia Financial Inc CLBK announced plans to buy Stewardship Financial for $15.75 per share in cash.
• ContraVir Pharmaceuticals, Inc. CTRV rose 29 percent to $9.14 on continued strength after the company recently announced results from a preclinical study of CRV431 showing 'significantly decreased the extent of fibrosis in a second animal model of liver fibrosis.'
• Beyond Meat, Inc. BYND gained 28 percent to $127.28 after the company reported stronger-than-expected results for its first quarter on Thursday.
• Zoom Video Communications, Inc. ZM shares rose 21.8 percent to $96.72 after the company reported upbeat earnings for its first quarter and issued strong second-quarter guidance.
• ReWalk Robotics Ltd. RWLK gained 20.7 percent to $6.34.
• Horizon Global Corporation HZN climbed 18.6 percent to $3.95 after the company reported initiation of process to explore sale of its Asia-Pacific segment.
• Senseonics Holdings, Inc. SENS shares rose 15.2 percent to $2.0850 after the company confirmed FDA approval for a non-adjunctive indication for the Eversense 90-day CGM system.
• Zumiez Inc. ZUMZ shares rose 14.4 percent to $21.35 after the company reported better-than-expected results for its first quarter.
• Workhorse Group Inc. WKHS gained 14.2 percent to $2.3749.
• La Jolla Pharmaceutical Company LJPC gained 14.1 percent to $11.69 on continued momentum after the company's Phase 2 Study of LJPC-401 in patients with hereditary hemochromatosis showed statistical significance in primary and secondary endpoints and was well tolerated.
• Neptune Wellness Solutions Inc NEPT gained 13.9 percent to $4.52 after the company signed a multi-year extraction agreement with Tilray.
• CRISPR Therapeutics AG CRSP rose 13.7 percent to $42.34 after the company entered into an exclusive licensing agreement to discover and develop gene editing therapies for the treatment of DMD and DM1.
• AGM Group Holdings Inc. AGMH gained 13.4 percent to $15.03.
• Tile Shop Holdings, Inc. TTS climbed 12.7 percent to $4.27.
• Barnes & Noble, Inc. BKS rose 11.2 percent to $6.63 after the company announced it will be acquired by Elliott at $6.50 per share.
• Teekay Corporation TK gained 10.6 percent to $3.12.
• Protagonist Therapeutics, Inc. PTGX surged 10.2 percent to $11.75.
• Flexible Solutions International Inc. FSI gained 10.1 percent to $3.38.
• Ocular Therapeutix, Inc. OCUL shares jumped 10 percent to $3.07.
• MongoDB, Inc. MDB gained 8.8 percent to $160.81.
• Alteryx, Inc. AYX shares rose 8.5 percent to $98.95.
• Riot Blockchain, Inc. RIOT shares gained 8 percent to $2.7311.
• Turkcell Iletisim Hizmetleri A.S. TKC shares rose 7.9 percent to $5.47.
• Perspecta Inc PRSP rose 6.4 percent to $22.92 after reporting better-than-expected results for its fourth quarter.
• Sanofi SNY rose 6.1 percent to $44.46 after the current CEO Brandicourt announced he would step down and Paul Hudson will be the new CEO on September 1st.
• Magnolia Oil & Gas Corporation MGY gained 5.7 percent to $11.49 after the company announced an exchange offer and consent solicitation relating to its outstanding warrants with the goal of simplifying the company's capital structure and reduce dilution from the warrants.
• PagerDuty, Inc. PD rose 4.9 percent to $49.87 after the company reported better-than-expected Q1 sales results. The company also issued Q2 and FY20 sales guidance.
• Vail Resorts, Inc. MTN rose 4.7 percent to $228.22 after the company reported upbeat earnings for its third quarter on Thursday.
• Caesars Entertainment Corporation CZR rose 4.6 percent to $9.55 after the WSJ reported the company is nearing a deal to merge with Eldorado Resorts. A New York Post report indicated Caesars stakeholder and activist investor Carl Icahn has rejected the deal.

Check out these big penny stock gainers and losers

Losers

• Jaguar Health, Inc. JAGX shares dipped 19.3 percent to $7.32.
• Charles & Colvard, Ltd. CTHR fell 17.5 percent to $1.6750. Charles & Colvard priced its 6.25 million share common stock offering at $1.60 per share.
• Motif Bio plc MTFB dropped 17 percent to $0.9375 on continued weakness after the FDA said an additional clinical trial of Iclaprim will be required before the agency can grant the company marketing approval for the drug, citing concerns about liver toxicity.
• Genocea Biosciences, Inc. GNCA fell 15.1 percent to $5.16.
• Aeterna Zentaris Inc. AEZS tumbled 14.3 percent to $2.11.
• Domo Inc DOMO dropped 14.2 percent to $27.26 after the company issued Q2 sales guidance below analyst estimates.
• DocuSign, Inc. DOCU fell 13.7 percent to $47.27 after the company reported a quarter-over-quarter decline in subscription growth, offsetting strong Q1 earnings and upbeat Q2 guidance.
• Aurora Mobile Limited JG dipped 12.6 percent to $5.47.
• Axovant Gene Therapies Ltd. AXGT dropped 8.8 percent to $5.19.
• Evolus, Inc. EOLS tumbled 8 percent to $15.48.
• CymaBay Therapeutics, Inc. CBAY shares dropped 7.7 percent to $10.52.
• American Equity Investment Life Holding Company AEL dropped 6.3 percent to $28.25 after the company announced that the board is no longer in talks for a potential transaction.
• Accuray Incorporated ARAY shares declined 6.2 percent to $3.48 after Goldman Sachs initiated coverage on the company's stock with a Buy rating and a price target of $111 per share.
• Talend S.A. TLND shares fell 5.9 percent to $40.21 after declining 3.61 percent on Thursday.